Vertex to buy Crinetics for $10 billion in rare-diseases push - Reuters
Vertex to buy Crinetics for $10 billion in rare-diseases push Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOX3N1NDFzcDNMSmVSODY1SEJGRm51Sl96QmtwWV9zMHA3RUZTRVlDenhJaG01alZQSU5KZUNWV2NFMFp6c0U5Xy1aZFZ2UXVmNWFGNk1HR1NMcGpJWHVpQjVtQWV2Z0FqMldWWHFwMlA2cHh1eDBtT19sem9BZ1ljblQta09WbWdBcjFzX3JVY2h2WlFsQ1VZ?oc=5" target="_blank">Vertex to buy Crinetics for $10 billion in rare-diseases push</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters
August 25, 2026 at 06:00 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMUS FDA approves Takeda, Protagonist's drug for rare blood cancer - Reuters
US FDA approves Takeda, Protagonist's drug for rare blood cancer Reuters
August 28, 2026 at 10:16 PMUS FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PMKimberly-Clark seeks EU approval for $40 billion Kenvue deal - Reuters
Kimberly-Clark seeks EU approval for $40 billion Kenvue deal Reuters
August 28, 2026 at 08:12 AMCanada to loan quantum startup Xanadu $140 million to build manufacturing plant - Reuters
Canada to loan quantum startup Xanadu $140 million to build manufacturing plant Reuters
August 28, 2026 at 05:41 PM